Position in AMGN
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$4,719,147
+$77,542 QoQ
Shares Held
13,032
-1.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#866
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglas Lane & Associates, LLC holds $414,684,195 across 11 Drug Manufacturers - General names. AMGN ranks #6 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
663,667 | $168,551,507 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
1,556,184 | $89,667,322 | |
| 3 | MRK |
Merck & Co., Inc.
|
552,155 | $70,951,917 | |
| 4 | GSK |
GSK plc
|
946,636 | $49,622,659 | |
| 5 | NVS |
Novartis AG
|
140,152 | $21,964,621 | |
| 6 | AMGN |
Amgen Inc
This page
|
13,032 | $4,719,147 | |
| 7 | LLY |
ELI LILLY & Co
|
2,861 | $3,431,569 | |
| 8 | ABBV |
AbbVie Inc.
|
9,961 | $2,506,586 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,719,147 | 13,032 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $4,641,605 | 13,192 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $4,266,813 | 13,036 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $3,802,080 | 13,473 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $3,736,667 | 13,383 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $4,249,230 | 13,639 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $3,747,481 | 14,378 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $4,620,491 | 14,340 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $4,499,592 | 14,401 | Shares | Sole | 2024-07-08 | |
| 2024-03-31 | $4,192,298 | 14,745 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $4,261,255 | 14,795 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $4,105,309 | 15,275 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $3,306,099 | 14,891 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $3,621,898 | 14,982 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $4,010,250 | 15,269 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,689,572 | 16,369 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $4,070,652 | 16,731 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $4,594,096 | 18,998 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $5,033,478 | 22,374 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $4,965,164 | 23,349 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $6,503,006 | 26,679 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $7,914,397 | 31,809 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $8,244,701 | 35,859 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $10,074,648 | 39,639 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $10,438,456 | 44,257 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $9,613,862 | 47,422 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||